Filter

Refine by collections

  • Advances and Future Directions in Pheochromocytoma and Paraganglioma (4)

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 4 of 4 items for :

  • neuroendocrine neoplasms x
  • Advances and Future Directions in Pheochromocytoma and Paraganglioma x
  • Refine by access: All content x
Clear All
Anne-Paule Gimenez-Roqueplo Université Paris Cité, PARCC, INSERM, Paris, France
Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France

Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed Close
,
Mercedes Robledo Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain

Search for other papers by Mercedes Robledo in
Google Scholar
PubMed Close
, and
Patricia L M Dahia Division of Hematology and Medical Oncology, Department Medicine, University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, Texas, USA
Mays Cancer Center at UTHSCSA, San Antonio, Texas, USA

Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed Close

entities. The fifth series of the WHO classification of endocrine and neuroendocrine tumors published in 2022 describes clearly PCC as part of the PGL family of tumors by defining PCC as a neuroendocrine neoplasm that originates from chromaffin cells of the

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0373
Volume/Issue:
Volume 30: Issue 4
Open access
David Taïeb Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France

Search for other papers by David Taïeb in
Google Scholar
PubMed Close
,
Christelle Fargette Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France

Search for other papers by Christelle Fargette in
Google Scholar
PubMed Close
,
Abhishek Jha Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Abhishek Jha in
Google Scholar
PubMed Close
, and
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed Close

PV Zeevaart JR Koster U Schibli R van der Meulen NP Muller C 2022 Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms . European Journal of Nuclear

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0375
Volume/Issue:
Volume 30: Issue 4
Free access
Liang Zhang Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Liang Zhang in
Google Scholar
PubMed Close
,
Tobias Åkerström Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Tobias Åkerström in
Google Scholar
PubMed Close
,
Kazhan Mollazadegan Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed Close
,
Felix Beuschlein Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich (USZ) and Univeristät Zürich (UZH), Zurich, Switzerland
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Felix Beuschlein in
Google Scholar
PubMed Close
,
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed Close
,
Britt Skogseid Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Britt Skogseid in
Google Scholar
PubMed Close
, and
Joakim Crona Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Joakim Crona in
Google Scholar
PubMed Close

Vanova KH Uher O Das S Patel M Meuter L Huynh TT Jha A Talvacchio S Knue M , 2023 Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis . Endocrine 79 171 – 179

Article Type:
Research Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0354
Volume/Issue:
Volume 30: Issue 7
Open access
Susan Richter Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany

Search for other papers by Susan Richter in
Google Scholar
PubMed Close
,
Timothy J Garrett Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA

Search for other papers by Timothy J Garrett in
Google Scholar
PubMed Close
,
Nicole Bechmann Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany

Search for other papers by Nicole Bechmann in
Google Scholar
PubMed Close
,
Roderick J Clifton-Bligh Cancer Genetics Laboratory, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, St Leonards, Australia
Department of Endocrinology, Royal North Shore Hospital, St Leonards, Australia

Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed Close
, and
Hans K Ghayee Department of Internal Medicine, Division of Endocrinology, University of Florida College of Medicine and Malcom Randall VA Medical Center, Gainesville, Florida, USA

Search for other papers by Hans K Ghayee in
Google Scholar
PubMed Close

has an advantage for non-polar, volatile compounds. MALDI as a third ionization approach most often is applied in imaging MS. PPGL and catecholamine metabolism Non-epithelial neuroendocrine neoplasms originating from neural crest-derived cells

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0376
Volume/Issue:
Volume 30: Issue 6
Open access